Study protocol of the B-CAST study: a multicenter, prospective cohort study investigating the tumor biomarkers in adjuvant chemotherapy for stage III colon cancer - Wikidata - awgldk - TriplyDB

Study protocol of the B-CAST study: a multicenter, prospective cohort study investigating the tumor biomarkers in adjuvant chemotherapy for stage III colon cancer

Study protocol of the B-CAST study: a multicenter, prospective cohort study investigating the tumor biomarkers in adjuvant chemotherapy for stage III colon cancer

http://www.wikidata.org/entity/Q34636336

about

FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial.

P2860

Q26851060-70A1B7C0-311D-45C3-975A-40ABEC8941B3 Q41822265-788BC8E4-2C96-4E11-96EC-F65E026E95C5

P2860

Study protocol of the B-CAST study: a multicenter, prospective cohort study investigating the tumor biomarkers in adjuvant chemotherapy for stage III colon cancer

http://www.wikidata.org/entity/Q34636336

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Study protocol of the B-CAST s ...... apy for stage III colon cancer

@ast

Study protocol of the B-CAST s ...... apy for stage III colon cancer

@en

Study protocol of the B-CAST s ...... apy for stage III colon cancer

@nl

type

label

Study protocol of the B-CAST s ...... apy for stage III colon cancer

@ast

Study protocol of the B-CAST s ...... apy for stage III colon cancer

@en

Study protocol of the B-CAST s ...... apy for stage III colon cancer

@nl

prefLabel

Study protocol of the B-CAST s ...... apy for stage III colon cancer

@ast

Study protocol of the B-CAST s ...... apy for stage III colon cancer

@en

Study protocol of the B-CAST s ...... apy for stage III colon cancer

@nl

P1433

Q34636336-AD6EBA55-F626-483C-AB2F-0C56E9EEA306

P1476

Q34636336-1E42F92A-8A06-4AF5-8889-B7E9415ABF1B

P2093

Q34636336-0742E369-8F6F-416C-829A-59C5ADFF53EA

Q34636336-10BDBC82-F267-4567-A13D-5F7452C6E3F1

Q34636336-3BA0827B-2EA6-46B0-A0D6-52F45CC5A7FC

Q34636336-3C946569-B2A9-4D9A-A3F2-CD816C34B811

Q34636336-4128B68A-E648-4D14-A070-16A764CE9200

Q34636336-4CDABDB3-F425-4FC9-B8D6-64C79C676B38

Q34636336-64DF9052-8CDB-42D1-AFBC-4BC349A012B8

Q34636336-6511C332-3412-4EE5-B617-7A19C49FF4E8

Q34636336-67067AE3-677F-4AFA-B96C-058BD41F1D52

Q34636336-7442060A-FE4D-488D-B772-941A4FBA204B

P2860

Q34636336-026391C3-3602-464F-8B23-733D8BEFAA87

Q34636336-2FA16464-9D1B-48B9-9BB8-0B1323B720F2

Q34636336-580BE39F-E251-4CF2-9E8C-FF4759F626E4

Q34636336-875B6FBF-8C56-4EBE-8357-6923B35BAFB3

Q34636336-893B31ED-DA65-4A09-B27D-E19C69B0D094

Q34636336-8CC1F7E3-BBE1-4C44-92CE-40E2AA99A34C

Q34636336-9948372A-9CD8-48C9-8CE3-E2D840F88A8B

Q34636336-A75A80D8-9F60-4073-9E8B-99F95EF8D1AC

Q34636336-A87450B8-8DBC-4063-A750-2F5696F809BE

Q34636336-ADD84F17-B9A9-454E-B3CD-A64B697D761F

P2888

Q34636336-0A660EA7-F694-4641-9B17-83CDBF9457F8

P304

Q34636336-0CEDA150-26E4-41E9-9F2C-6A596199BB06

P31

Q34636336-23821B91-EC21-435F-98B4-11D97E43AFC5

P356

Q34636336-091B61D3-ACD2-4274-BAC4-67140B88B459

P407

Q34636336-39268295-D3C2-4FBC-8A90-52C6D70A3BD5

P478

Q34636336-E5C1F722-94A6-4CD1-96C5-3AE104E897B5

P577

Q34636336-654EF552-9294-4861-8407-5B0A6DF43324

P5875

Q34636336-EA23BA41-C7CD-46E2-800C-E9906410B4D2

P6179

Q34636336-826DDDB2-8B57-48C7-8EDF-E46634645D1F

P698

Q34636336-0FC86E81-E405-442D-9CB5-C0B3DAA96FD2

P921

Q34636336-595558A1-6DAA-493F-B136-ED795F044B35

Q34636336-AF0605D5-6629-4992-973F-4E9FD7B8E424

Q34636336-C1A03FC2-011C-4CBD-95E4-842E72128D7A

P932

Q34636336-BB1AB08B-CAB3-499C-B57E-95D61CDB9E35

P356

1471-2407-13-149

P1433

P1476

Study protocol of the B-CAST s ...... apy for stage III colon cancer

@en

P2093

Akiyoshi Kanazawa

http://www.w3.org/2001/XMLSchema#string

Genichi Nishimura

http://www.w3.org/2001/XMLSchema#string

Ichinosuke Hyodo

http://www.w3.org/2001/XMLSchema#string

Keiichi Takahashi

http://www.w3.org/2001/XMLSchema#string

Keiko Miyakoda

http://www.w3.org/2001/XMLSchema#string

Ken Kondo

http://www.w3.org/2001/XMLSchema#string

Kenichi Sugihara

http://www.w3.org/2001/XMLSchema#string

Kenjiro Kotake

http://www.w3.org/2001/XMLSchema#string

Masaki Mori

http://www.w3.org/2001/XMLSchema#string

Masazumi Okajima

http://www.w3.org/2001/XMLSchema#string

P2860

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.

Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues.

Capecitabine as adjuvant treatment for stage III colon cancer.

Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial

The epidermal growth factor receptor as a target for colorectal cancer therapy.

A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.

Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.

P2888

1471-2407-13-149

P304

149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-13-149

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236082205

http://www.w3.org/2001/XMLSchema#string

P6179

1016554727

http://www.w3.org/2001/XMLSchema#string

P698

23530572

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

3618253

http://www.w3.org/2001/XMLSchema#string